BIOLOGICAL ACTIVITIES OF IC201 ((3S, 8E)-1, 3-DIHYDROXY-8-DECEN-5-ONE), A LOW MOLECULAR WEIGHT IMMUNOMODULATOR PRODUCED BY STREPTOMYCES

IC201 was found in cultured broth of Streptomyces cirratus as an antitumor antibiotic which was effective in retarding growth of the established solid tumor of Ehrlich carcinoma by treatment starting 8 days after tumor inoculation. It retarded growth of the established solid tumor of IMC carcinoma b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 1989/06/25, Vol.42(6), pp.952-959
Hauptverfasser: MIZUTANI, SHIGETOSHI, ODAI, HIDEHARU, MASUDA, TORU, IIJIMA, MASATOMI, OSONO, MICHIYO, HAMADA, MASA, NAGANAWA, HIROSHI, ISHIZUKA, MASAAKI, TAKEUCHI, TOMIO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:IC201 was found in cultured broth of Streptomyces cirratus as an antitumor antibiotic which was effective in retarding growth of the established solid tumor of Ehrlich carcinoma by treatment starting 8 days after tumor inoculation. It retarded growth of the established solid tumor of IMC carcinoma but had no cytotoxicity at 100 μg/ml. IC201 treatment kept NK cell activity of tumor-bearing mice at normal level and stimulated cytostatic activity of peritoneal macrophages. It stimulated phagocytosis of yeast and phorbol myristate acetateelicited superoxide production by peritoneal macrophages. The addition of IC201 to P388D1 cell cultures enhanced release of interleukin 1 (IL-1) into cultured supernatant but it affected lipopolysaccharide-induced IL-1 production. Although the addition to macrophage-depleted cultures did not show any stimulatory effect, mixed lymphocyte culture reaction was augmented in cultures using spleen cells as stimulator cells taken from mice given IC201. Results indicate that IC201 primarily activates macrophages and the activation may cause modulation of immune responses.
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.42.952